{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:25:59Z","timestamp":1790141159114,"version":"4.0.1"},"reference-count":45,"publisher":"Jaypee Brothers Medical Publishing","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.59556\/japi.72.0692","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T09:18:57Z","timestamp":1751275137000},"page":"71-76","source":"Crossref","is-referenced-by-count":5,"title":["Does Adopting Western Low-density Lipoprotein Cholesterol Targets Expose Indians to a Higher Risk of Cardiovascular Events? Expert Opinion From the Lipid Association of India"],"prefix":"10.59556","volume":"72","author":[{"given":"Raman","family":"Puri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimal","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P Barton","family":"Duell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S S","family":"Iyengar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadanand","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upendra","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayasagar","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Agarwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurpreet Singh","family":"Wander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Hazra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumitra","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S K","family":"Wangnoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Hamid","family":"Zargar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banshi","family":"Saboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamal","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod M","family":"Vijan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarat","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi R","family":"Kasliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P C","family":"Manoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M U","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan C","family":"Chag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Bordoloi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saravanan","family":"Palanippan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmender","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Murugnathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep Kumar","family":"Dabla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagaraj","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangesh H","family":"Tiwaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devaki R","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charanjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitull","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan D","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","reference":[{"key":"key20250630091851_B1","doi-asserted-by":"crossref","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2023 update: a report from the American Heart Association. Circulation 2023;147(8):e93\u2013e621.","DOI":"10.1161\/CIR.0000000000001137"},{"issue":"(Suppl):","key":"key20250630091851_B2","doi-asserted-by":"crossref","first-page":"S419\u2013","DOI":"10.1016\/j.ihj.2018.05.002","article-title":"Low quality cardiovascular care is important coronary risk factor in India.","volume":"70","author":"Gupta","year":"2018;","journal-title":"Indian Heart J"},{"key":"key20250630091851_B3","doi-asserted-by":"crossref","first-page":"937\u2013","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case control study.","volume":"364:","author":"Yusuf","year":"2004;","journal-title":"Lancet"},{"key":"key20250630091851_B4","doi-asserted-by":"crossref","first-page":"e96808.","DOI":"10.1371\/journal.pone.0096808","article-title":"Prevalence of dyslipidemia in urban and rural India: The ICMR\u2013INDIAB Study.","volume":"9:","author":"Joshi","year":"2014;","journal-title":"PLoS ONE"},{"issue":"(2):","key":"key20250630091851_B5","doi-asserted-by":"crossref","first-page":"e1\u2013","DOI":"10.1016\/j.jacl.2022.11.002","article-title":"Management of diabetic dyslipidemia in Indians: expert consensus statement from the Lipid Association of India.","volume":"17","author":"Puri","year":"2023;","journal-title":"J Clin Lipidol"},{"key":"key20250630091851_B6","first-page":"S7\u2013","article-title":"Lipid Association of India expert consensus statement on management of dyslipidemia in Indians 2016: part 1.","volume":"64:","author":"Iyengar","year":"2016;","journal-title":"J Assoc Physicians India"},{"issue":"(39):","key":"key20250630091851_B7","doi-asserted-by":"crossref","first-page":"2999\u2013","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS Guidelines for the management of dyslipidaemias.","volume":"37","author":"Catapano","year":"2016;","journal-title":"Eur Heart J"},{"issue":"(25):","key":"key20250630091851_B8","first-page":"e1082\u2013","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"139","author":"Grundy","year":"2019;","journal-title":"Circulation"},{"issue":"(25):","key":"key20250630091851_B9","doi-asserted-by":"crossref","first-page":"2387\u2013","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes.","volume":"372","author":"Cannon","year":"2015;","journal-title":"N Engl J Med"},{"issue":"(22):","key":"key20250630091851_B10","doi-asserted-by":"crossref","first-page":"2097\u2013","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome.","volume":"379","author":"Schwartz","year":"2018;","journal-title":"N Engl J Med"},{"issue":"(11):","key":"key20250630091851_B11","first-page":"8\u2013","article-title":"Lipid Association of India expert consensus statement on management of dyslipidemia in Indians 2020: part III.","volume":"68","author":"Puri","year":"2020;","journal-title":"J Assoc Phys India"},{"key":"key20250630091851_B12","doi-asserted-by":"crossref","first-page":"e1\u2013","DOI":"10.1016\/j.jacl.2020.01.006","article-title":"Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal antibodies: expert consensus statement from Lipid Association of India.","volume":"14:","author":"Puri","year":"2020;","journal-title":"J Clin Lipidol"},{"issue":"(18):","key":"key20250630091851_B13","doi-asserted-by":"crossref","first-page":"1713\u2013","DOI":"10.1056\/NEJMoa1615664","article-title":"FOURIER steering committee and Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease.","volume":"376","author":"Sabatine","year":"2017;","journal-title":"N Engl J Med"},{"key":"key20250630091851_B14","first-page":"1408\u2013","article-title":"Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial.","volume":"44:","author":"Schwartz","year":"2023;","journal-title":"Eur Heart J"},{"key":"key20250630091851_B15","doi-asserted-by":"crossref","first-page":"1962\u2013","DOI":"10.1016\/S0140-6736(17)32290-0","article-title":"Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial.","volume":"390:","author":"Giugliano","year":"2017;","journal-title":"Lancet"},{"key":"key20250630091851_B16","doi-asserted-by":"crossref","first-page":"547\u2013","DOI":"10.1001\/jamacardio.2017.0083","article-title":"Long-term safety and efficacy of achieving very low levels of low-density lipoprotein cholesterol: a prespecified analysis of the IMPROVE-IT trial.","volume":"2:","author":"Giugliano","year":"2017;","journal-title":"JAMA Cardiol"},{"key":"key20250630091851_B17","doi-asserted-by":"crossref","first-page":"111\u2013","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.","volume":"41:","author":"Mach","year":"2020;","journal-title":"Eur Heart J"},{"issue":"(3):","key":"key20250630091851_B18","doi-asserted-by":"crossref","first-page":"e351\u2013","DOI":"10.1016\/j.jacl.2024.01.006","article-title":"Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: consensus statement IV.","volume":"18","author":"Puri","year":"2024;","journal-title":"J Clin Lipidol"},{"issue":"(11):","key":"key20250630091851_B19","first-page":"6\u2013","article-title":"Fighting the atherosclerotic cardiovascular disease epidemic: declaring war on lipids by Lipid Association of India.","volume":"68","author":"Mehta","year":"2020;","journal-title":"J Assoc Physicians India"},{"key":"key20250630091851_B20","unstructured":"Deaths due to coronary heart diseases in the EU. https:\/\/ec.europa.eu\/eurostat\/web\/products-eurostat-news\/-\/edn-20200928-1."},{"key":"key20250630091851_B21","doi-asserted-by":"crossref","first-page":"301\u2013","DOI":"10.1016\/j.gheart.2014.11.004","article-title":"Biomarkers of coronary artery disease differ between Asians and Caucasians in the general population.","volume":"10:","author":"Gijsberts","year":"2015;","journal-title":"Global Heart"},{"issue":"(1):","key":"key20250630091851_B22","doi-asserted-by":"crossref","first-page":"7.","DOI":"10.5334\/gh.882","article-title":"A comparison of lipids and apo B in Asian Indians and Americans.","volume":"16","author":"Singh","year":"2021;","journal-title":"Global Heart"},{"issue":"(32):","key":"key20250630091851_B23","doi-asserted-by":"crossref","first-page":"2459\u2013","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.","volume":"38","author":"Ference","year":"2017;","journal-title":"Eur Heart J"},{"issue":"(6):","key":"key20250630091851_B24","doi-asserted-by":"crossref","first-page":"410\u2013","DOI":"10.1161\/CIRCULATIONAHA.120.052430","article-title":"Quantifying and understanding the higher risk of atherosclerotic cardiovascular disease among South Asian individuals: results from the UK Biobank prospective cohort study.","volume":"144","author":"Patel","year":"2021;","journal-title":"Circulation"},{"issue":"(7):","key":"key20250630091851_B25","doi-asserted-by":"crossref","first-page":"724\u2013","DOI":"10.1016\/j.jacc.2007.10.038","article-title":"Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial.","volume":"51","author":"Miller","year":"2008;","journal-title":"J Am Coll Cardiol"},{"issue":"(1 Suppl 1):","key":"key20250630091851_B26","doi-asserted-by":"crossref","first-page":"S99\u2013","DOI":"10.1016\/j.dsx.2015.10.002","article-title":"Discordance between lipid markers used for predicting cardiovascular risk in patients with type 2 diabetes.","volume":"10","author":"Modi","year":"2016;","journal-title":"Diabetes Metab Syndr"},{"issue":"(12):","key":"key20250630091851_B27","doi-asserted-by":"crossref","first-page":"1302\u2013","DOI":"10.1001\/jama.2012.366","article-title":"Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.","volume":"307","author":"Boekholdt","year":"2012;","journal-title":"JAMA"},{"issue":"(38):","key":"key20250630091851_B28","doi-asserted-by":"crossref","first-page":"e295.","DOI":"10.3346\/jkms.2023.38.e295","article-title":"Triglyceride-rich lipoproteins and remnant cholesterol in cardiovascular disease.","volume":"38","author":"Heo","year":"2023;","journal-title":"J Korean Med Sci"},{"issue":"(4):","key":"key20250630091851_B29","doi-asserted-by":"crossref","first-page":"381\u2013","DOI":"10.1161\/01.ATV.5.4.381","article-title":"Relative contribution of triglyceride-rich lipoprotein particle size and number to plasma triglyceride concentration.","volume":"5","author":"Poapst","year":"1985;","journal-title":"Arteriosclerosis"},{"issue":"(27):","key":"key20250630091851_B30","doi-asserted-by":"crossref","first-page":"2410\u2013","DOI":"10.1093\/eurheartj\/ehae258","article-title":"Discordance among apo B, non-high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention.","volume":"45","author":"Sniderman","year":"2024;","journal-title":"Eur Heart J"},{"key":"key20250630091851_B31","doi-asserted-by":"crossref","first-page":"286\u2013","DOI":"10.1001\/jama.297.3.286","article-title":"Risk factors for early myocardial infarction in South Asians compared with individuals in other countries.","volume":"297:","author":"Joshi","year":"2007;","journal-title":"JAMA"},{"issue":"(3):","key":"key20250630091851_B32","doi-asserted-by":"crossref","first-page":"154\u2013","DOI":"10.1016\/j.ihj.2024.06.003","article-title":"Establishing apolipoprotein-B and non-high-density-lipoprotein-C goals in Indian population: a cross-sectional study.","volume":"76","author":"Berry","year":"2024:","journal-title":"Indian Heart J"},{"key":"key20250630091851_B33","doi-asserted-by":"crossref","first-page":"247\u2013","DOI":"10.4330\/wjc.v8.i3.247","article-title":"Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: current state and future directions.","volume":"8:","author":"Bilen","year":"2016;","journal-title":"World J Cardiol"},{"issue":"(20):","key":"key20250630091851_B34","doi-asserted-by":"crossref","first-page":"2835\u2013","DOI":"10.1001\/jama.1986.03380200073024","article-title":"Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.","volume":"256","author":"Castelli","year":"1986;","journal-title":"JAMA"},{"issue":"(4):","key":"key20250630091851_B35","doi-asserted-by":"crossref","first-page":"305\u2013","DOI":"10.1016\/j.recesp.2011.10.021","article-title":"High-density lipoprotein and cardiovascular risk reduction: promises and realities.","volume":"65","author":"Santos-Gallego","year":"2012;","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"(2):","key":"key20250630091851_B36","doi-asserted-by":"crossref","first-page":"182\u2013","DOI":"10.1016\/S0026-0495(98)90217-7","article-title":"Elevated lipoprotein(a) levels in South Asians in North America.","volume":"47","author":"Anand","year":"1998;","journal-title":"Metabolism"},{"issue":"(2):","key":"key20250630091851_B37","doi-asserted-by":"crossref","first-page":"81\u2013","DOI":"10.1111\/j.1520-037X.2005.3766.x","article-title":"High-density lipoprotein subclass distribution in individuals of Asian Indian descent: the National Asian Indian Heart Disease Project.","volume":"8","author":"Superko","year":"2005;","journal-title":"Prev Cardiol"},{"issue":"(12):","key":"key20250630091851_B38","doi-asserted-by":"crossref","first-page":"1472\u2013","DOI":"10.1161\/CIRCULATIONAHA.118.034311","article-title":"Lipoprotein(a) levels and the risk of myocardial infarction among 7 ethnic groups.","volume":"139","author":"Par\u00e9","year":"2019;","journal-title":"Circulation"},{"key":"key20250630091851_B39","first-page":"42\u2013","article-title":"Lipoprotein(a) and ASCVD risk.","volume":"68:","author":"Puri","year":"2020;","journal-title":"J Assoc Physicians India"},{"issue":"(3):","key":"key20250630091851_B40","doi-asserted-by":"crossref","first-page":"e308\u2013","DOI":"10.1016\/j.jacl.2024.03.001","article-title":"A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice.","volume":"18","author":"Koschinsky","year":"2024;","journal-title":"J Clin Lipidol"},{"issue":"(1):","key":"key20250630091851_B41","first-page":"e1\u2013","article-title":"Atherosclerotic cardiovascular disease in South Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American Heart Association.","volume":"138","author":"Volgman","year":"2018;","journal-title":"Circulation"},{"key":"key20250630091851_B42","doi-asserted-by":"crossref","first-page":"701\u2013","DOI":"10.1038\/s41569-024-01039-5","article-title":"The LDL cumulative exposure hypothesis: evidence and practical applications.","volume":"21:","author":"Ference","year":"2024;","journal-title":"Nat Rev Cardiol"},{"issue":"(9753):","key":"key20250630091851_B43","doi-asserted-by":"crossref","first-page":"1670\u2013","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.","volume":"376","author":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration,","year":"2010;","journal-title":"Lancet"},{"issue":"(11):","key":"key20250630091851_B44","doi-asserted-by":"crossref","first-page":"1033\u2013","DOI":"10.1056\/NEJMoa1806747","article-title":"Mendelian randomization study of ACLY and cardiovascular disease.","volume":"380","author":"Ference","year":"2019;","journal-title":"N Engl J Med"},{"key":"key20250630091851_B45","doi-asserted-by":"crossref","first-page":"402\u2013","DOI":"10.1016\/j.jacl.2021.03.007","article-title":"Prevention of atherosclerotic cardiovascular disease in South Asians in the US: a clinical perspective from the National Lipid Association.","volume":"15:","author":"Kalra","year":"2021;","journal-title":"J Clin Lipidol"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T09:19:04Z","timestamp":1751275144000},"score":1,"resource":{"primary":{"URL":"https:\/\/japi.org\/article\/japi-72-10-71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["10.59556\/japi.72.0692"],"URL":"https:\/\/doi.org\/10.59556\/japi.72.0692","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}